Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
105 participants
INTERVENTIONAL
2013-07-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients
NCT00610324
Daily Chlorexidine Bath for Health Care Associated Infection Prevention
NCT05485051
4% Chlorhexidine Gluconate Daily Bathing for Prevention of Hospital-acquired Infections in Intensive Care Settings
NCT03639363
Daily Chlorhexidine Bathing and Infection Rates in Critically-ill Patients
NCT02033187
Chlorhexidine to Prevent Catheter-related Urinary Tract Infection
NCT05712434
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chlorhexidine
Washing of perineal area and proximal first 5 centimeters of catheter from mea, done by 15 ml of Chlorhexidine 0.2%, 3 times a day for 10 days.
Chlorhexidine
15 ml .2%, 3 imes a day for 10 days /external use for Washing perinea area and catheter first 5 centimeters
Povidone-Iodine
Washing of perineal area and proximal first 5 centimeters of catheter from mea, done by 15 ml of Povidone-iodine 10%, 3 times a day for 10 days.
Povidone-iodine
15 ml 10%, 3 imes a day for 10 days /external use for Washing perinea area and catheter first 5 centimeters
Normal saline
Washing of perineal area and proximal first 5 centimeters of catheter from mea, done by 15 ml of Normal saline 0.9%, 3 times a day for 10 days.
Normal saline
15 ml .9%, 3 imes a day for 10 days /external use for Washing perinea area and catheter first 5 centimeters
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Povidone-iodine
15 ml 10%, 3 imes a day for 10 days /external use for Washing perinea area and catheter first 5 centimeters
Chlorhexidine
15 ml .2%, 3 imes a day for 10 days /external use for Washing perinea area and catheter first 5 centimeters
Normal saline
15 ml .9%, 3 imes a day for 10 days /external use for Washing perinea area and catheter first 5 centimeters
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must have 18-55 years old
* Men subjects must doing circumcision already
* Urinary catheter must be apply in a standard method by researcher or via her supervision
Exclusion Criteria
* Malignant disease such as prostate or uterine cancer
* History of recurrent urinary infection
* Congenital urinary system disorders
* history of allergy
* Immunodeficiency disorders
* Urinary system intervention in past sixth months
* Urinary infection at study start
* Positive urine analysis or urine culture results in first 3 days of study
* Abdominal or pelvic surgery
* Women having period during study
* Any allergic reaction or dermatitis resulted from applying study solutions
* Appearing genital wounds
* Diabetes mellitus
* Wound in genital area
* Discharging, transferring or dying in first week of study
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mashhad University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seyedreza Mazloum
Faculty member of Medical Surgical Nursing Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seyedreza Mazloum, Ph.D.
Role: STUDY_CHAIR
Medical Surgical Nursing Department, Mashhad University of Medical Sciences
Kamran Mohammadnia, Ms.
Role: STUDY_DIRECTOR
Postgraduate Department, Mashhad University of Medical Sciences
Tayyebe Pourghaznein, Ms.
Role: STUDY_DIRECTOR
Medical Surgical Nursing Department, Mashhad University of Medical Sciences
Ebrahim Alijanpoor, Specialist
Role: STUDY_DIRECTOR
Anesthesia Department, Babol University of medical scienses
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shahid Beheshti Hospital
Babol, Mazandaran, Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MUMS910212
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.